Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075307 · ClinicalTrials.gov registry record · NA
Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage
A NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02075307: Completed NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT02075307 is a NA study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02075307, a NA study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Obesity usually brings with it disturbances in the body that increase the chances of developing serious diseases like diabetes and cancer. These disturbances include one or more symptoms of a condition called "metabolic syndrome" that often leads to diabetes. High levels of damage to the DNA that makes up our chromosomes have also been observed in obese people. It is possible that these two disturbances are connected. The goal of this project is to test this whether consumption of blueberries will improve these abnormalities.
Primary Outcome
DNA double-stranded breaks (DSBs) will be measured.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Blueberry Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-04-04 |
| Phase | NA |
What the finished NCT02075307 record still lists
NCT02075307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02075307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02075307 about?
NCT02075307 is a clinical study titled "Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage". Obesity usually brings with it disturbances in the body that increase the chances of developing serious diseases like diabetes and cancer. These disturbances include one or more symptoms of a condition called "metabolic syndrome" that often leads to diabetes. High levels of damage to the DNA that ma...
What is the current status of trial NCT02075307?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-01. Estimated completion is 2017-04-04.
What interventions are being tested in trial NCT02075307?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Blueberry Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02075307?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02075307's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia